Physician profile
Paras Bharatkumar Patel
NPI 1083988729
$746.66
in general payments reported to CMS, 2019-2025
9 companies · $654 in 2025
The $654 reported for 2025 was more than what 86% of Oral and Maxillofacial Pathology providers received nationally (typical 2025 total: $90.97).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.89 · 2024: $44.82 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $273.07 | 2025 | Trumatch |
| Geistlich Pharma, North America, INC. | $125.52 | 2025 | Biomaterials |
| Straumann USA LLC | $112.97 | 2025 | |
| Axogen | $107.33 | 2025 | |
| Nobel Biocare USA | $47.89 | 2021 | |
| Dentsply Sirona INC | $22.94 | 2024 | Suresmile |
| Biohorizons Implant Systems INC. | $21.88 | 2024 | Biohorizons |
| Hologic Sales and Service, LLC | $18.56 | 2025 | Aptima |
| Voco America INC. | $16.50 | 2025 | Profluorid L, Futurabond U, Voco Profluorid Varnish |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paras Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.